Prot #KO-MEN-001: A Phase 1/2 First in Human Study of the Menin-MLL (KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date1/15/20 → 1/15/26

Funding

  • Pharm-Olam International Ltd. ((OE) Prot #KO-MEN-001 // (OE) Prot #KO-MEN-001)
  • Kura Oncology, Inc. ((OE) Prot #KO-MEN-001 // (OE) Prot #KO-MEN-001)